Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis
- 1 October 2011
- journal article
- case report
- Published by Elsevier BV in Journal of Hepatology
- Vol. 55 (4), 820-827
- https://doi.org/10.1016/j.jhep.2010.12.041
Abstract
No abstract availableKeywords
Funding Information
- Agencia Española del Medicamento and Fondo de Investigación Sanitaria (FIS 07-0980, SAS PI 0082/207, PS 09/01384)
This publication has 40 references indexed in Scilit:
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshopHepatology, 2010
- Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sexHepatology, 2009
- Clinical Pattern of Zileuton-Associated Liver InjuryDrug Safety, 2007
- Hepatic Findings in Long-Term Clinical Trials of XimelagatranDrug Safety, 2005
- Antidepressant-induced hepatotoxicityExpert Opinion on Drug Safety, 2003
- Drug-induced liver diseasesJournal of Hepatology, 2000
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Amoxycillin-clavulanic acid-erythromycin cross-liver toxicity: a case reportJournal of Hepatology, 1994
- Criteria of drug-induced liver disorders: Report of an International Consensus MeetingJournal of Hepatology, 1990